Project Grant 2205111
Award Date
6/1/22
Completion Date
5/31/23
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Controlpoint Inc. (ED9REAQHGML9)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Carlsbad, CA 92010, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,362 provides funding to RT Microdx Inc., a minority-owned small business, to develop a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to enable rapid, reliable, and affordable at-home pathogen detection without requiring an expensive tabletop device. The anticipated technical outcomes include a disposable,...
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a low-cost, multimodal medical instrument for use in veterinary clinics. The instrument will visualize, monitor, and target the delivery of a proprietary photosensitive compound, silicon naphthalocyanine nanoparticles (SINC-NP), to detect and eliminate cancerous tissue in companion animals. The $274,999 award to Therafluor...
Under a $997,781 cooperative agreement awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, Nanopath Inc. - a woman-owned small business - is developing an integrated point-of-care system for rapid pathogen identification and characterization. The system utilizes proprietary nanosensor technology to detect target nucleic acid sequences directly from patient samples, eliminating the need for bacterial culture or nucleic...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 aims to develop a rapid point-of-care diagnostic test to accurately detect ocular herpes (HSV-1) infections. The award recipient, Teardx, LLC, a small business based in New York, will focus on reformatting a previously successful laboratory test into a user-friendly diagnostic tool suitable for urgent care settings. The project objectives are to optimize the test to...
This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $331,189 to the University of Central Florida (UCF) aims to develop an affordable, portable platform for virus detection in resource-limited environments. The project integrates protein engineering and electrochemical biosensor technologies to create a single-temperature, nucleic acid sequence-based amplification technique for virus detection. Key innovations include the use of...
Cobio Diagnostics Inc. received a $256,000 Project Grant award from the National Science Foundation on April 1, 2021 to support work concluding on March 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and education. Specifically, the grant funds Cobio Diagnostics' "SBIR PHASE I: PHAGE-AMPLIFIED IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST" project. This...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $305,000 to Resonantia Diagnostics, Inc. to develop a transformative point-of-care diagnostic platform capable of rapidly identifying pathogens and determining their antimicrobial susceptibility. The project aims to achieve three key technical objectives: (1) demonstrating accurate antimicrobial susceptibility testing at very low pathogen loads, (2)...
This $242,687 federal Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop a next-generation nanopore biosensor technology for the ultrasensitive detection and quantification of multiple infectious disease biomarkers at the point-of-care. The key objectives are to: (1) optimize a highly sensitive, robust, and reproducible nanopore biosensor; (2) enable specific biomarker detection through automated immunoprecipitation and novel signal...